InsiderTrades

Form 4 for EQ Equillium, Inc.

Accepted 2026-03-16 00:00:00 ET · period of report 2026-03-13 · accession 0001797818-26-000008 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-03-16 2026-03-13 EQ Zedelmayer Christine COO, Sr. VP S - Sale+OE $2.50 -120.3K 62.6K -66% -$300.8K
D 2026-03-16 2026-03-13 EQ Zedelmayer Christine COO, Sr. VP M - OptEx $0.79 +120.3K 182.9K +192% +$95.0K
D 2026-03-16 2026-03-13 EQ Zedelmayer Christine COO, Sr. VP M - OptEx $0.00 -120.3K 54.7K -69% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-13 S D 120,312 $2.50 62,586 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.515 to $2.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
2 Common Common Stock 2026-03-13 M A 120,312 $0.79 182,898 D — —
3 Derivative Employee Stock Option (right to buy) 2026-03-13 M D 120,312 $0.00 54,688 D $0.79 · — to 2033-01-02 120,312 Common Stock (F3) Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.